103028-31-5

Basic information

• Product Name: 4-BROMO-8-METHOXYQUINOLINE
• Synonyms: 4-Bromo-8-methoxy-1-azanaphthalene, 4-Bromoquinolin-8-yl methyl ether;4-BroMo-8-Methoxyquinoline;4-BROMO-8-METHOXYQUINOLINE
• CAS NO: 103028-31-5
• Molecular Formula: C₁₀H₈BrNO
• Molecular Weight: 238.08
• EINECS: -0
• Mol File: 103028-31-5.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 336.9 °C at 760 mmHg
• Flash Point: 157.5 °C
• Appearance: /
• Density: 1.516 g/cm³
• Vapor Pressure: 0.000213mmHg at 25°C
• Refractive Index: 1.64
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BROMO-8-METHOXYQUINOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-8-METHOXYQUINOLINE(103028-31-5)
• EPA Substance Registry System: 4-BROMO-8-METHOXYQUINOLINE(103028-31-5)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-41
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 103028-31-5(Hazardous Substances Data)

Usage

Chemical Properties

yellow powder

InChI:InChI=1/C10H8BrNO/c1-13-9-4-2-3-7-8(11)5-6-12-10(7)9/h2-6H,1H3

Upstream product

• 103862-09-5 4-bromo-8-methoxy-quinoline-2-carboxylic acid 
• 21269-34-1 4-hydroxy-8-methoxyquinoline 
• 2929-14-8 4-hydroxy-8-methoxy-quinoline-2-carboxylic acid 
• 90-04-0 2-methoxy-phenylamine 

Downstream Products

• 139399-63-6 4-bromo-8-hydroxyquinoline 

Relevant articles and documents

Nitrohydroxyquinoline derivative and preparation method and application thereof

The invention discloses a nitrohydroxyquinoline derivative and a preparation method and application thereof. Specifically, the invention discloses a compound shown as a general formula (I), a preparation method of the compound, a pharmaceutical composition containing the compound, and an application of the compound in treatment on infectious diseases or cancers. The compound disclosed by the invention has different anti-tumor activities and can be developed into a medicine for treating tumors. The definition of each group in the general formula (I) is the same as that in the specification.

PYRANOPYRAZOLE AND PYRAZOLOPYRIDINE IMMUNOMODULATORS FOR TREATMENT OF AUTOIMMUNE DISEASES

Pyranoyrazoles and pyrazolopyridines of formula I or formula II are disclosed: (I), (II) These compounds inhibit Coagulation Factor Xlla in the presence of thrombin and other coagulation factors. They are useful to treat autoimmune diseases.

Study on Relationship Between Fluorescence Properties and Structure of Substituted 8-Hydroxyquinoline Zinc Complexes

Organic light-emitting diodes (OLEDs) produced from 8-hydroxyquinoline metal complexes play a vital role in modern electroluminescent devices. In this manuscript, a series of 8-hydroxyquinoline derivatives were synthesized by different methods and their corresponding zinc metal complexes were prepared. The UV and fluorescence properties of the complexes were measured aiming to understand the effect of substituents at the quinoline ring on the fluorescence properties of the complexes. When the C-5 of 8-hydroxyquinoline was replaced by halogen group, the fluorescence emission wavelengths had been red-shifted, at the same time, blue-shifted of fluorescence emission wavelength was observed when the C-5 position of 8-hydroxyquinoline was substituted by electron-withdrawing group. When the C-4 position of 8-hydroxyquinolie was substituted by methyl or the C-5 position was substituted by sulfonic acid group, the corresponding zinc complexes had higher fluorescence intensity than 8-hydroxyquinolie zinc.